+1803294983432
customer.service@microbix.com
External Quality Controls
SARS Complete Panel
Respiratory Viral Panel
DxTM Viral Transport Medium
Custom Vial Filling Solutions
Proudly Supporting Over 100+ Customers with Leading Diagnostic Solutions
“Microbix approached us before the pandemic started, and the relationship developed so easily and quickly that we formalized our collaboration in 2020. Along with their excellent technical capabilities, they have successfully developed relationships with many diagnostics manufacturers around the world. We are pleased that our FLOQSwabs® are their exclusive choice for their growing line of swab formatted QAPs™”
Gaetano Natale, Chief Commercial Officer.
The Microbix Difference
Our Quality Commitment
By choosing Microbix Biosystems Inc., you are aligning with a partner certified to the latest ISO standards and dedicated to delivering products that truly set the benchmark for quality in the industry.
Decades of Expertise
With over three decades of experience in the global diagnostics industry, Microbix has established a reputation as a leading infectious disease diagnostic manufacturer.
Widespread Customer Acceptance
Microbix’s products have consistently earned widespread recognition and trust from customers due to their superior reliability.
Download Our Full Product Catalogue
News & Insights from Our Diagnostics Experts
-
Microbix Reports Results for Q2 Fiscal 2025
Microbix reports results for its second quarter and first half of fiscal 2025 ended March 31, 2025 (“Q2” and “H1”). Sales for Q2 and H1 reflected differential growth between Antigens (up) and QAPs™ (down), alongside a markedly-improved gross margin.
-
Microbix & Aurevia Introduce Novel EQA Scheme
Microbix & Aurevia announce a pilot external quality assessment (“EQA”) program to help clinical laboratories establish their proficiency at using molecular diagnostic methods (e.g., PCR tests) to diagnose bacterial vaginosis (“BV”).
-
Microbix Schedules Release of Results for Q2 Fiscal 2025
Microbix announces that it expects to file the financial statements, management disclosure and analysis, and results news release for its second quarter of fiscal 2025 ended March 31, 2025 (“Q2 2025”) prior to the start of trading on May 15, 2025.
Speak to a Microbix Products Customer Service Representative
Let our knowledgeable experts help you secure your Microbix infectious disease diagnostics products supply today.